High chemerin and CMKLR1 proteins in European patients with HCC are related to adverse clinical parameters such as the T stage, vessel invasion, grading, and UICC stage, indicating a tumor-promoting effect of this receptor and its ligand. Here, RARRES2 is linked to hepatocellular carcinoma.